Ryan Nipp to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications Ryan Nipp has written about Carcinoma, Pancreatic Ductal.
Connection Strength
1.607
-
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Pancreas. 2017 02; 46(2):183-189.
Score: 0.452
-
Predicting a response to FOLFIRINOX in pancreatic cancer. J Natl Cancer Inst. 2015 Aug; 107(8).
Score: 0.402
-
Impact of electronic patient-reported outcomes (ePRO) presentation in pancreatic cancer tumor board discussions on cancer outcomes: the INSPIRE intervention. BMC Cancer. 2025 Dec 30; 26(1):182.
Score: 0.209
-
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat Cancer. 2021 11; 2(11):1124-1135.
Score: 0.157
-
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2019 04; 269(4):733-740.
Score: 0.131
-
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2019 07; 24(7):945-954.
Score: 0.129
-
Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Ann Surg Oncol. 2018 Dec; 25(13):4027-4034.
Score: 0.127